Manufacturer GATC Biotech  |  Available Worldwide
Comprehensive profile of all mutations present in the exome

GATCLIQUID ONCOEXOME by GATC Biotech product image

0 Scientists have reviewed this product

Write the First Review

No Reviews

GATCLIQUID ONCOEXOME is the the first non-invasive service for whole exome sequencing (WES) of circulating tumour DNA (ctDNA). This service allows for a comprehensive profile of all mutations present in the protein coding regions of the genome of suspected cancer patients in cases where limited information on clinically relevant tumour-associated mutations is available.  Features:

  • Analysis of novel variants, recurrent or frequent somatic mutations in ctDNAome sequencing of cell-free (cfDNA)
  • Coverage of more than 24,000 exons with a sensitivity of 5%
  • Optimised protocols for low-input ctDNA extraction from plasma
  • Proprietary workflows for obtaining libraries of high complexity
  • Expert data processing with QIAGEN Ingenuity Variant Analysis (optional)
  • Carried out under diagnostic standards (ISO17025 accreditation)